Scorpius Holdings Inc (SCPX)

Scorpius Holdings Inc has recorded no insider trading activity within the past three months. The most recent transaction occurred on May 14, 2021, involving a sale of shares. Historical data indicates various buying and selling patterns by company personnel over several years, with no significant recent market participation by corporate officers or directors.
Ticker: SCPX Exchange: PNK


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scorpius Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.7
PRENDERGAST JOHN K A Non-Executive Director
Transaction date
Sale
Price
23.13
Quantity 21,412 -21.0%
Value US$3,937,919
1.5
Smith Edward B III Non-Executive Director
Transaction date
Sale
Price
479.14
Quantity 93,205 +28.5%
Value US$3,551,667
KHARITONOV MICHAEL Non-Executive Director
Transaction date
Purchase
Price
374.59
Quantity 18,495 +31.0%
Value US$1,818,274
Price Melissa VP Clinical/Regulatory Affairs Officer
Transaction date
Purchase
Price
4.30
Quantity 346 +100.0%
Value US$1,488
Price Melissa VP Clinical/Regulatory Affairs Officer
Transaction date
Purchase
Price
4.30
Quantity 346 +inf%
Value US$1,488
Wolf Jeffrey Alan Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
4.10
Quantity 346 +10.4%
Value US$1,419
Wolf Jeffrey Alan Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
4.05
Quantity 400 +13.7%
Value US$1,620
Wolf Jeffrey Alan Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
4.15
Quantity 1,754 +151.2%
Value US$7,279
Belsky Paul Non-Executive Director
Transaction date
Purchase
Price
4.15
Quantity 1,265 +2.8%
Value US$5,250
Belsky Paul Non-Executive Director
Transaction date
Purchase
Price
4.07
Quantity 1,235 +2.8%
Value US$5,026
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2021-05-18 2021-05-14 S Sale Non-Executive Director
21,412 -21.0%
23.13
US$3,937,919
21,412 -21.0% 23.13 US$3,937,919
2020-11-13 2020-11-12 S Sale Non-Executive Director
93,205 +28.5%
479.14
US$3,551,667
93,205 +28.5% 479.14 US$3,551,667
2016-03-23 2016-03-23 B Purchase KHARITONOV MICHAEL Non-Executive Director
18,495 +31.0%
374.59
US$1,818,274
18,495 +31.0% 374.59 US$1,818,274
2014-06-06 2014-06-05 B Purchase Price Melissa

VP Clinical/Regulatory Affairs

Officer
346 +100.0%
4.30
US$1,488
346 +100.0% 4.30 US$1,488
2014-06-06 2014-06-05 B Purchase Price Melissa

VP Clinical/Regulatory Affairs

Officer
346 +inf%
4.30
US$1,488
346 +inf% 4.30 US$1,488
2014-05-20 2014-05-19 B Purchase Wolf Jeffrey Alan

Chief Executive Officer

Executive Director Large shareholder
346 +10.4%
4.10
US$1,419
346 +10.4% 4.10 US$1,419
2014-05-20 2014-05-19 B Purchase Wolf Jeffrey Alan

Chief Executive Officer

Executive Director Large shareholder
400 +13.7%
4.05
US$1,620
400 +13.7% 4.05 US$1,620
2014-05-20 2014-05-19 B Purchase Wolf Jeffrey Alan

Chief Executive Officer

Executive Director Large shareholder
1,754 +151.2%
4.15
US$7,279
1,754 +151.2% 4.15 US$7,279
2014-05-16 2014-05-16 B Purchase Belsky Paul Non-Executive Director
1,265 +2.8%
4.15
US$5,250
1,265 +2.8% 4.15 US$5,250
2014-05-16 2014-05-16 B Purchase Belsky Paul Non-Executive Director
1,235 +2.8%
4.07
US$5,026
1,235 +2.8% 4.07 US$5,026